ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics

ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. Eurofins Genescan Expands Food and Feed Safety Programs Eurofins GeneScan announces the hiring of Lulu Kurman in the position of Manager of Food Safety Systems, to have oversight of the food safety, traceability and vendor certification programs being offered by Eurofins GeneScan, and to serve as liaison with Eurofins Certification in Paris for implementation of ISO-22000, BRC and GMP+ accreditation programs. Eurofins Genescan Expands Food and Feed Safety Programs Eurofins GeneScan announces the hiring of Lulu Kurman in the position of Manager of Food Safety Systems, to have oversight of the food safety, traceability and vendor certification programs being offered by Eurofins GeneScan, and to serve as liaison with Eurofins Certification in Paris for implementation of ISO-22000, BRC and GMP+ accreditation programs. Eurofins Genescan Expands Food and Feed Safety Programs Eurofins GeneScan announces the hiring of Lulu Kurman in the position of Manager of Food Safety Systems, to have oversight of the food safety, traceability and vendor certification programs being offered by Eurofins GeneScan, and to serve as liaison with Eurofins Certification in Paris for implementation of ISO-22000, BRC and GMP+ accreditation programs. Eurofins Genescan Expands Food and Feed Safety Programs Eurofins GeneScan announces the hiring of Lulu Kurman in the position of Manager of Food Safety Systems, to have oversight of the food safety, traceability and vendor certification programs being offered by Eurofins GeneScan, and to serve as liaison with Eurofins Certification in Paris for implementation of ISO-22000, BRC and GMP+ accreditation programs. Eurofins Genescan Expands Food and Feed Safety Programs Eurofins GeneScan announces the hiring of Lulu Kurman in the position of Manager of Food Safety Systems, to have oversight of the food safety, traceability and vendor certification programs being offered by Eurofins GeneScan, and to serve as liaison with Eurofins Certification in Paris for implementation of ISO-22000, BRC and GMP+ accreditation programs. 2006 Healthy Foods European Summit to be Held in London Otober 31 and November 1 More than twenty of the world’s leading experts in the nutrition and health sector will address the second two-day Healthy Foods European Summit to be held in central London from Tuesday 31st October to Wednesday 1st November, 2006. 2006 Healthy Foods European Summit to be Held in London Otober 31 and November 1 More than twenty of the world’s leading experts in the nutrition and health sector will address the second two-day Healthy Foods European Summit to be held in central London from Tuesday 31st October to Wednesday 1st November, 2006. 2006 Healthy Foods European Summit to be Held in London Otober 31 and November 1 More than twenty of the world’s leading experts in the nutrition and health sector will address the second two-day Healthy Foods European Summit to be held in central London from Tuesday 31st October to Wednesday 1st November, 2006. 2006 Healthy Foods European Summit to be Held in London Otober 31 and November 1 More than twenty of the world’s leading experts in the nutrition and health sector will address the second two-day Healthy Foods European Summit to be held in central London from Tuesday 31st October to Wednesday 1st November, 2006. 2006 Healthy Foods European Summit to be Held in London Otober 31 and November 1 More than twenty of the world’s leading experts in the nutrition and health sector will address the second two-day Healthy Foods European Summit to be held in central London from Tuesday 31st October to Wednesday 1st November, 2006. 2006 Healthy Foods European Summit to be Held in London Otober 31 and November 1 More than twenty of the world’s leading experts in the nutrition and health sector will address the second two-day Healthy Foods European Summit to be held in central London from Tuesday 31st October to Wednesday 1st November, 2006. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	London, England ReGen Therapeutics Plc. ('ReGen'), announces that it has today entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America(the 'Agreement'). ReGen's shares are traded on the AIM Market of the London Stock Exchange plc (RGT) and are quoted on the Pink Sheets of the United States over-the-counter market in the form of American Depositary Receipts (REGUY:PK). Headquartered in San Clemente, California, Metagenics is a leading developer, manufacturer and marketer of nutraceuticals, dedicated to researching and evaluating the effects of natural ingredients on genetic expression and protein activity. The Agreement is conditional on, amongst other things, satisfactory completion of toxicology testing on Colostrinin(TM) and of due diligence by Metagenics on the Colostrinin(TM) manufacturing facilities. Subject to satisfactory completion of the conditions of the Agreement and requisite U.S. regulatory filings, ReGen currently anticipates launch of a human nutraceutical containing Colostrinin(TM)during the first half of 2007. ReGen produces bulk Colostrinin(TM) in South Dakota and will now work with Metagenics to establish the best commercialisation strategy to introduce Colostrinin(TM) into the North American market. The Agreement provides Metagenics with the exclusive right to market Colostrinin(TM) via healthcare professionals with an option to extend this exclusivity into the retail channels, such as drugstores and supermarkets. This option is valid for six months after first launch of a human nutraceutical containing Colostrinin(TM) and is subject to Metagenics being able to identify retail partners acceptable to ReGen and the achievement of certain performance criteria. Percy Lomax, ReGen Executive Chairman and Chief Executive Officer said, 'This agreement with Metagenics is of great significance to ReGen in that it recognises the commercial potential of Colostrinin(TM) in the North American nutraceutical market. After much discussion both parties have decided that the most efficient way to bring this opportunity to fruition is by working together more closely and as an experienced nutraceutical company we see Metagenics as an ideal long-term partner'. Jeff Katke, Chairman and Chief Executive Officer of Metagenics, added, 'We are very pleased to conclude this exclusive licence agreement with ReGen for the introduction of Colostrinin(TM) in North America. ReGen and Metagenics share a commitment to investment in scientific research in order to set new, higher standards of safety and effectiveness of nutraceuticals. Colostrinin(TM) will be an important part of our science-based neurological product line, and we believe it will provide a substantial benefit in maintaining healthy brain function and mental acuity for the ageing patients of over 30,000 healthcare practitioners that we serve in North America.' About ReGen Therapeutics Plc ReGen Therapeutics is a UK listed Biotech company which is developing three business lines - human and veterinary nutraceuticals, prescription pharmaceuticals for the treatment of neurodegenerative diseases and a clinical research organisation which oversees Phase I and Phase II both for ReGen and external customers. ReGen's business strategy is to develop its nutraceutical and pharmaceutical products to a state where they can be licensed out and marketed by a third party. Its only direct sales are currently through its clinical research organisation. www.regentherapeutics.com About Metagenics, Inc. Metagenics, Inc. is a leading developer, manufacturer and marketer of science-based nutraceuticals and medical foods sold to healthcare practitioners worldwide. The company is headquartered in San Clemente, California. with manufacturing and research facilities located in Gig Harbor, Washington- including its MetaProteomics(R) Nutrigenomics Research Center and its Functional Medicine Research Center(SM) for human clinical research. Metagenics holds multiple proprietary formula patents and produces over 400 research-based products to optimize health. Metagenics demonstrates its commitment to purity and quality through its certifications for Good Manufacturing Practices (GMP) from the National Nutritional Foods Association, NSF International, and the Therapeutic Goods Administration of Australia. www.metagenics.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software